Published in J Pharm Sci on June 01, 1970
Psychosocial functioning and depression: distinguishing among antecedents, concomitants, and consequences. Psychol Bull (1988) 2.14
Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke (1999) 1.59
Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. J Clin Invest (1979) 1.37
Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. Proc Natl Acad Sci U S A (1982) 1.05
An approach to ascertain probands with a non-traditional risk factor for carotid atherosclerosis. Atherosclerosis (1999) 0.99
Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption. Cancer Res (1988) 0.96
An evaluation of the response of the microvasculature in tumors in C3H mice to vasoactive drugs. Bibl Anat (1977) 0.95
Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. Neurosurgery (1985) 0.93
Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier. Cancer Res (1985) 0.91
Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents. Clin Cancer Res (1998) 0.90
Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts. J Nucl Med (1994) 0.89
Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings. AJNR Am J Neuroradiol (1991) 0.87
Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent delivery. Trans Am Neurol Assoc (1979) 0.84
Dexamethasone decreases the delivery of tumor-specific monoclonal antibody to both intracerebral and subcutaneous tumor xenografts. Neurosurgery (1993) 0.84
The effect of oxidation on sorbitol pathway kinetics. Diabetes (1986) 0.83
Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings. J Comput Assist Tomogr (1994) 0.83
Osmotic blood-brain barrier opening to IgM monoclonal antibody in the rat. Am J Physiol (1986) 0.83
Intraaortic balloon counterpulsation: its influence alone and combined with various pharmacological agents on regional myocardial blood flow during experimental acute coronary occlusion. Ann Thorac Surg (1981) 0.80
Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system. Neurosurgery (1987) 0.80
Oxygen consumption rates of grunion (Leuresthes tenuis) embryos exposed to the petroleum hydrocarbon, benzo[a]pyrene. Environ Res (1984) 0.79
Pharmacology and neurotoxicity of cis-diamminedichloroplatinum, bleomycin, 5-fluorouracil, and cyclophosphamide administration following osmotic blood-brain barrier modification. Cancer Res (1983) 0.78
Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery. Neurosurgery (1984) 0.78
Histologic and skeletal abnormalities in benzo(a)pyrene-treated rainbow trout alevins. Arch Environ Contam Toxicol (1984) 0.78
Methods in laboratory investigation. Identification and evaluation of histopathology at microelectrode puncture sites. Lab Invest (1983) 0.78
In vitro metabolism and in vivo binding of benzo(a)pyrene in the California killifish (Fundulus parvipinnis) and speckled sanddab (Citharicthys stigmaeous). Arch Environ Contam Toxicol (1986) 0.78
Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors. Cancer Treat Rep (1981) 0.77
Correlation of regional disease and in vivo PO2 in rat mammary adenocarcinoma. Am J Pathol (1983) 0.76
Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison. Can J Clin Pharmacol (2000) 0.76
African cobra bite. Br Med J (1971) 0.75
Developmental and cytogenetic abnormalities induced in the purple sea urchin by environmental levels of benzo(a)pyrene. Arch Environ Contam Toxicol (1983) 0.75
Preliminary observations of oxygen levels in microcirculation of tumors in C3H mice. Adv Exp Med Biol (1976) 0.75
Pollutant flow in a marine food web in the Los Angeles harbor. Proc West Pharmacol Soc (1980) 0.75
Introductory study of vasoactive serum from patients with toxemia of pregnancy. Proc West Pharmacol Soc (1977) 0.75
Gross examination of the placenta. Clin Obstet Gynecol (1976) 0.75
Preliminary observations of the effect of serum from patients with toxemia of pregnancy on the microcirculation. Bibl Anat (1973) 0.75
An introductory study of the influence and role of prolactin in mammary tumor growth. Proc West Pharmacol Soc (1977) 0.75
PCB, DDT, and benzo(a)pyrene in raw and pan-fried white croaker (Genyonemus lineatus). Bull Environ Contam Toxicol (1983) 0.75
An automated method for enteric coating small batches of tablets. Am J Hosp Pharm (1967) 0.75
Observations of the microcirculation in spontaneous mammary tumors in C3H mice. Bibl Anat (1975) 0.75
Historical development of procaine from cocaine. N Z Dent J (1969) 0.75
Vasoactive effect of sera from preeclamptic patients. Am J Obstet Gynecol (1982) 0.75
Response of the microvasculature in experimental mammary tumors in C3H mice to selected vasoactive drugs. Proc West Pharmacol Soc (1975) 0.75
Use of the denervated guinea pig diaphragm to elucidate the site of action of selected sea snake venoms. Proc West Pharmacol Soc (1975) 0.75
Determination of cyclic AMP and cyclic GMP levels in fish (Microstomus pacificus) epitheliomas. Comp Biochem Physiol A Comp Physiol (1983) 0.75
Management of manipulative behavior of anorexia nervosa patients. J Psychiatr Nurs Ment Health Serv (1977) 0.75
Use of cholesterol esters (liquid crystals) for detection of internal hemorrhage. Proc West Pharmacol Soc (1978) 0.75
A comparison of pharmaceutical flavorants extracted from selected subtropical fruits. Am J Hosp Pharm (1971) 0.75
Hydrocarbon pollution of the oceans: secondary metabolites of a carcinogen in fish. Proc West Pharmacol Soc (1979) 0.75
Oxygen levels in tumors in C3H mice during hyperthermia: initial data. Adv Exp Med Biol (1978) 0.75
Drug distribution studies: a possible new approach using intravital microscopy and a spatially discriminate isotope detector. Proc West Pharmacol Soc (1979) 0.75
Interrelationship between PO2, morphology and perfusion in rat mammary adenocarcinoma (AD) using combined in vivo microcathode/India ink injection/freeze substitution techniques. Adv Exp Med Biol (1983) 0.75
Sorbitol/fructose metabolism in the lens. Exp Eye Res (1985) 0.75
Pharmacology of snake venoms. Clin Toxicol (1970) 0.75
Cyclic nucleotide levels in a human breast carcinoma transplanted into athymic nude mice. Proc West Pharmacol Soc (1978) 0.75
Control of parasitic infestations in killifish (Fundulus parvipinnis). Lab Anim Sci (1981) 0.75
A microscopic method for quantifying the response of the microvasculature in mice to vasoactive drugs. Proc West Pharmacol Soc (1976) 0.75
Oral papillomas in Genyonemus lineatus (white croakers). Etiological considerations. Prog Exp Tumor Res (1976) 0.75
Salicylate release characteristics of selected polyethylene glycol suppositories. J Pharm Sci (1973) 0.75
Dibutyryl cAMP involvement in experimental mammary tumor growth. Proc West Pharmacol Soc (1975) 0.75